Morgan Stanley’s Rani Therapeutics RANI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.61K | Sell |
7,020
-7,566
| -52% | -$3.89K | ﹤0.01% | 7114 |
|
|
2025
Q1 | $18.4K | Buy |
14,586
+8,085
| +124% | +$10.2K | ﹤0.01% | 6600 |
|
|
2024
Q4 | $8.91K | Buy |
6,501
+1,250
| +24% | +$1.71K | ﹤0.01% | 6847 |
|
|
2024
Q3 | $11.3K | Buy |
5,251
+2,300
| +78% | +$4.97K | ﹤0.01% | 6682 |
|
|
2024
Q2 | $11.2K | Buy |
2,951
+500
| +20% | +$1.9K | ﹤0.01% | 6636 |
|
|
2024
Q1 | $7.62K | Sell |
2,451
-7,951
| -76% | -$24.7K | ﹤0.01% | 6790 |
|
|
2023
Q4 | $34.5K | Buy |
10,402
+9,502
| +1,056% | +$31.5K | ﹤0.01% | 6478 |
|
|
2023
Q3 | $1.96K | Sell |
900
-1,010
| -53% | -$2.2K | ﹤0.01% | 7135 |
|
|
2023
Q2 | $7.87K | Buy |
1,910
+1,380
| +260% | +$5.69K | ﹤0.01% | 6890 |
|
|
2023
Q1 | $2.74K | Sell |
530
-1,640
| -76% | -$8.46K | ﹤0.01% | 7183 |
|
|
2022
Q4 | $12.8K | Sell |
2,170
-2,544
| -54% | -$15K | ﹤0.01% | 6847 |
|
|
2022
Q3 | $45K | Buy |
4,714
+616
| +15% | +$5.88K | ﹤0.01% | 6457 |
|
|
2022
Q2 | $43K | Buy |
4,098
+820
| +25% | +$8.6K | ﹤0.01% | 6679 |
|
|
2022
Q1 | $44K | Sell |
3,278
-495
| -13% | -$6.64K | ﹤0.01% | 6768 |
|
|
2021
Q4 | $61K | Buy |
+3,773
| New | +$61K | ﹤0.01% | 6718 |
|